Oral transmucosal fentanyl citrate for the treatment of breakthrough pain in cancer patients: an overview of its pharmacological and clinical characteristics.

Journal of opioid management

Volumn 1, Issue 1, 2005, Pages 36-40

  Mystakidou, Kyriaki ^a   Katsouda, Emmanuela ^a   Parpa, Efi ^a   Tsiatas, Marinos L ^a   Vlahos, Lambros ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

FENTANYL; NARCOTIC ANALGESIC AGENT;

CLINICAL TRIAL; HUMAN; METABOLISM; MOUTH MUCOSA; NEOPLASM; ORAL DRUG ADMINISTRATION; PAIN; REVIEW; TREATMENT OUTCOME;

ADMINISTRATION, ORAL; ANALGESICS, OPIOID; CLINICAL TRIALS; FENTANYL; HUMANS; MOUTH MUCOSA; NEOPLASMS; PAIN; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 33847772352     PISSN: 15517489     EISSN: None     Source Type: Journal    
DOI: 10.5055/jom.2005.0010     Document Type: Review

References (21)